0001140361-18-031328.txt : 20180703
0001140361-18-031328.hdr.sgml : 20180703
20180703185127
ACCESSION NUMBER: 0001140361-18-031328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAY DEBANJAN
CENTRAL INDEX KEY: 0001706863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 18938997
MAIL ADDRESS:
STREET 1: C/O CYTOMX THERAPEUTICS, INC.
STREET 2: 151 OYSTER POINT BLVD, SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2018-07-02
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001706863
RAY DEBANJAN
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2018-07-02
4
M
0
3000
1.2599
A
8928
D
Common Stock
2018-07-02
4
S
0
3000
22.56
D
5928
D
Stock Option (Right to Buy)
1.2599
2018-07-02
4
M
0
3000
0.00
D
2023-12-10
Common Stock
3000
2710
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
100% of the shares subject to the option are fully vested and exercisable.
/s/ Debanjan Ray
2018-07-03